References

SPEG (Scottish Paediatric Endocrine Group)
NHS National Services Scotland
  1. Williamson s, Greene SA, Thyrotoxicosis in childhood. Annual Report 2005-2006, BPSU 2005; 19:52-53
  2. Perrild H, Gruters-Kieslich A, Feldt-Rasmussen U, Grant D, Martino E, Kayser L, Delange F. Diagnosis and treatment of thyrotoxicosis in childhood. A European questionnaire study. Eur J Endocrinol 1994; 131: 467-473.
  3. Wong GW, Cheng PS. Increasing incidence of childhood Graves' disease in Hong Kong: a follow-up study. Clinical Endocrinology 2001; 54:547-50.
  4. Rivkees AS, Sklar C, Freemark M. The management of Graves' disease in children, with special emphasis on radioiodine treatment. J Clin Endocrinol Metab1998; 83: 3767-3774.
  5. Shulman DI, Muhar I, Jorgensen EV, Diamond FB, Bercu BB, Root AW. Autoimmune hyperthyroidism in prepubertal children and adolescents: comparison of clinical and biochemical features at diagnosis and responses to medical therapy. Thyroid 1997; 7: 755 -760.
  6. Hamburger JI. Management of hyperthyroidism in children and adolescents.J Clin Endocrinol Metab 1985: 60:1019-1024.
  7. Cheetham T, A randomised study of two anti-thyroid drug treatment regimens in young people with thyrotoxicosis Protocol Version 1.2, http://www.bsped.org.uk/professional/projects/thyrotoxicosis/Thyrotoxicos
    isProtocol_v1.2_2007.pdf
  8. Raza J, Hindmarsh PC, Brook CG. Thyrotoxicosis in children: thirty years' experience. Acta Paediatrica. 1999;88:937-41
  9. Romaldini JH. Bromberg N. Werner RS. Tanaka LM. Rodrigues HF. Werner MC. Farah CS. Reis LC. Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism. J Clin Endocrinol Metab 1983; 57:563-70
  10. Waldhausen JH. Controversies related to the medical and surgical management of hyperthyroidism in children. Seminars in Pediatric Surgery.6(3):121-7, 1997 Aug.
  11. Perrild H, Lavard L, Brock-Jacobsen B. Clinical aspects and treatment of juvenile Graves’ disease. Exp. Clin. Endocrinol. Diabetes; 105 (Suppl. 4): 55–7. 1999 Page 16 of 16
  12. Bergman, P; Auldist, Aw; Cameron, F.Review of the outcome of management of Graves’ disease in children and adolescents. Journal of Paediatrics and Child Health 37(2):176-182, 2001.
  13. G Birrell and T Cheetham,Juvenile thyrotoxicosis; can we do better? Arch. Dis. Child Aug 2004; 89: 745 - 750.
  14. Nebesio TD, Siddiqui AR, Pescovitz OH, et al. Time course to hypothyroidism after fixed-dose radioablation therapy of Graves’ disease in children. J Pediatr 2002;141:99–103.
  15. KRASSAS, G.E., SEGNI, M. and WIERSINGA, W.M., 2005 Oct. Childhood Graves' ophthalmopathy: results of a European questionnaire study. European Journal of Endocrinology, 153(4), pp. 515-521.
  16. Holm. I.A., MANSON, J.E., MICHELS, K.B., ALEXANDER, E.K., WILLETT, W.C. and UTIGER, R.D., 2005. Smoking and other lifestyle factors and the risk of Graves' hyperthyroidism. Archives of Internal Medicine, 165(14), pp. 1606-1611